Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral 2DG in Epilepsy
NCT05605301Phase 2Completed
- Sponsor
- University of Virginia
- Start
- Sep 2022
- Primary completion
- Feb 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of 2-deoxy-d-glucose in epilepsy, seizure, sponsored by University of Virginia. Started Sep 2022; status: completed.
02
Drugs
2-deoxy-d-glucose
03
Conditions
epilepsyseizure
Beyond the preview
Go deeper on NCT05605301.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05605301.